Polypharmacy and Integrated Care
Mair, A. (in press)
Polypharmacy and Integrated Care. In V. Amelung, V. Stein, E. Suter, N. Goodwin, E. Nolte, & R. Balicer (Eds.), Handbook Integrated Care. Cham: Springer. https://doi.org/10.1007/978-3-030-69262-9
Appropriate polypharmacy: a barometer for integrated care
Mair, A., Antoniadou, E., Hendry, A., & Gabrovec, B. (2021)
Appropriate polypharmacy: a barometer for integrated care. Journal of Integrated Care, 29(2), 204-214. https://doi.org/10.1108/jica-04-2020-0019
Polypharmacy, the concurrent use of multiple medicines by one individual, is a common and growing challenge driven by an ageing population and the growing number of pe...
Current evidence on the impact of medication optimization or pharmacological interventions on frailty or aspects of frailty: a systematic review of randomized controlled trials
Pazan, F., Petrovic, M., Cherubini, A., Onder, G., Cruz-Jentoft, A. J., Denkinger, M., …Wehling, M. (2021)
Current evidence on the impact of medication optimization or pharmacological interventions on frailty or aspects of frailty: a systematic review of randomized controlled trials. European Journal of Clinical Pharmacology, 77(1), 1-12. https://doi.org/10.1007/s00228-020-02951-8
Frailty and adverse drug effects are linked in the fact that polypharmacy is correlated with the severity of frailty; however, a causal relation has not been proven...
Addressing the Challenge of Polypharmacy
Mair, A., Wilson, M., & Dreischulte, T. (2020)
Addressing the Challenge of Polypharmacy. Annual Review of Pharmacology and Toxicology, 60(1), 661-681. https://doi.org/10.1146/annurev-pharmtox-010919-023508
Polypharmacy describes the concomitant use of multiple medicines and represents a growing global challenge attributable to aging populations with an increasing prevalence of m...
Quality Prescribing for Chronic Pain: A Guide for Improvement
Chronic Pain Expert group, , & Scottish Government, . (2019)
Quality Prescribing for Chronic Pain: A Guide for Improvement. Edinburgh: Scottish Government
Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases
Bousquet, J. J., the ARIA Study Group, , Schünemann, H. J., Togias, A., Erhola, M., Hellings, P. W., …the MASK Study Group, . (2019)
Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases. Clinical and Translational Allergy, 9, https://doi.org/10.1186/s13601-019-0279-2
In all societies, the burden and cost of allergic and chronic respiratory diseases are increasing rapidly. Most economies are struggling to deliver modern health ca...
The polypharmacy programme in Scotland: realistic prescribing
Mair, A., Wilson, M., & Dreischulte, T. (2019)
The polypharmacy programme in Scotland: realistic prescribing. Prescriber, 30(8), 10-16. https://doi.org/10.1002/psb.1779
Since 2012, NHS Scotland has published a series of polypharmacy guidelines to help clinicians address the many medication‐related problems arising from multimorbidity. Here, A...
Medication safety in polypharmacy: technical report
Mair, A. (2019)
Medication safety in polypharmacy: technical report. Geneva: WHO
As the population ages more people are likely to suffer from multiple long term illness and take multiple medications. It is essential to therefore take a person-centred appro...
Medication Safety in Transitions of Care: Technical Report
World Health Organisation, . (2019)
Medication Safety in Transitions of Care: Technical Report. Geneva: WHO
Medication discrepancies impact almost every patient that moves across transitions of care, e.g. admission to or discharge from hospital. WHO urges countries to prioritise ear...
Medication Safety in High Risk Situations
World Health Organization, . (2019)
Medication Safety in High Risk Situations. Geneva: World Health Organization